Martindale Pharma improves Aurum pre-filled syringe packaging
To ensure ease of use and improve patient safety
The Aurum syringes are used for on-the-spot administration of drugs where high visibility and simple drug identification is crucial.
The Brentwood, Essex-based firm has redesigned the range to enhance ease of use and help improve patient safety. Specific improvements include new colour-differentiated packaging; colour-differentiated translucent boxes that confirm contents; and colour-differentiated labels. In addition the firm has improved tamper-evident labels and the packaging is latex-free and Luer Lock fitting.
The firm says its new colour-differentiated packaging meets national and international colour differentiation standards on syringe labelling and also the Royal College of Anaesthetists recommendations on syringe labelling in critical care.
You may also like
Trending Articles
Upcoming event
You may also like
Regulatory
NHS, MHRA and Medicines UK launch Project Revive to tackle medicine shortages
NHS England, the MHRA and Medicines UK have launched Project Revive, a collaborative pilot designed to address critical medicines shortages by fast-tracking dormant MHRA-approved licences and creating dedicated NHS purchasing arrangements to improve long-term supply resilience
Packaging
Autopack highlights best in class solutions at Packaging Innovations and Empack 2026
Leading independent integrator of packaging lines Autopack will showcase a range of its automated and semi-automated equipment at Packaging Innovations and Empack 2026, which takes place at Birmingham’s NEC from 11-12 February. The Hereford-based business will welcome visitors to come to stand V132 to find the right solution for their packaging formats and materials
Regulatory
testo Saveris 1 update automates environmental monitoring workflows for pharma compliance
Testo Saveris, global leader in measurement solutions, has announced the latest software update for its testo Saveris 1 Environmental Monitoring System, designed to address the evolving needs of the pharmaceutical industry by delivering reliable and precise monitoring of key metrics, including temperature and humidity
Regulatory
FDA accepts first quality control standard for mesenchymal stromal cells
The FDA has accepted the first dedicated quality control protocol for mesenchymal stromal cells, recognising the Tasly 3P Characterisation Assay and setting a new regulatory benchmark for MSC safety and clinical performance
You need to be a subscriber to read this article.
Click here to find out more.
Click here to find out more.